Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage.

Abstract:

:Successful gene transfer into articular cartilage is a prerequisite for gene therapy of articular joint disorders. In the present study we tested the hypothesis that recombinant adeno-associated virus (rAAV) vectors are capable of effecting gene transfer in isolated articular chondrocytes in vitro, articular cartilage tissue in vitro, and sites of articular damage in vivo. Using an rAAV vector carrying the Escherichia coli beta-galactosidase gene (lacZ) under the control of the cytomegalovirus (CMV) immediate-early promoter/enhancer (rAAV-lacZ), transduction efficiency exceeded 70% for isolated normal human adult articular chondrocytes, and osteoarthritic human articular chondrocytes. These were comparable to the transduction efficiency obtained with neonatal bovine articular chondrocytes. Transduction of explant cultures of articular cartilage resulted in reporter gene expression within the tissue of all three cartilage types to a depth exceeding 450 microm, which remained present until 150 days. When rAAV-lacZ vectors were applied to femoral chondral defects and osteochondral defects in vivo in a rat knee model, reporter gene expression was achieved for at least 10 days after transduction. These data suggest that AAV-based vectors can efficiently transduce and stably express foreign genes in articular chondrocytes, including chondrocytes of normal and osteoarthritic human articular cartilage. The data further suggest that the same rAAV vectors are capable of transducing chondrocytes in situ within their native matrix to a depth sufficient to be of potential clinical significance. Finally, the data demonstrate that these rAAV vectors are capable of effectively delivering recombinant genes to chondral and osteochondral defects in vivo.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Madry H,Cucchiarini M,Terwilliger EF,Trippel SB

doi

10.1089/104303403321208998

keywords:

subject

Has Abstract

pub_date

2003-03-01 00:00:00

pages

393-402

issue

4

eissn

1043-0342

issn

1557-7422

journal_volume

14

pub_type

杂志文章
  • Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.

    abstract::Gene delivery via murine-based recombinant retroviral vectors is currently widely used in gene therapy clinical trials. The vectors are engineered to be replication defective by replacing the structural and nonstructural genes of a cloned infectious retrovirus with a therapeutic gene of interest. The retroviral partic...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.10-1231

    authors: Martineau D,Klump WM,McCormack JE,DePolo NJ,Kamantigue E,Petrowski M,Hanlon J,Jolly DJ,Mento SJ,Sajjadi N

    更新日期:1997-07-01 00:00:00

  • Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

    abstract::Abstract Our studies have shown that coinjection of conventional single-stranded adeno-associated virus 2 (ssAAV2) vectors carrying the enhanced green fluorescent protein (EGFP) gene with self-complementary (sc) AAV2-T cell protein tyrosine phosphatase (TC-PTP) and scAAV2-protein phosphatase-5 (PP5) vectors resulted i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.100

    authors: Jayandharan GR,Zhong L,Sack BK,Rivers AE,Li M,Li B,Herzog RW,Srivastava A

    更新日期:2010-03-01 00:00:00

  • Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.

    abstract::The inherited deficiency in adenosine deaminase (ADA), which results in severe combined immunodeficiency, is generally regarded as an optimal model for the development of human somatic gene therapy. The ideal target for the correction of ADA deficiency and other lympho-hematopoietic disorders would be the hematopoieti...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1991.2.3-203

    authors: Cournoyer D,Scarpa M,Mitani K,Moore KA,Markowitz D,Bank A,Belmont JW,Caskey CT

    更新日期:1991-10-01 00:00:00

  • Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis.

    abstract::Retinal ganglion cells (RGCs) play a key role in the pathogenesis and development of glaucoma. The present study aims to investigate the underlying mechanism of long noncoding RNA growth arrest-specific transcript 5 (GAS5) in glaucoma development through regulating the apoptosis of RGCs. Rat models of chronic glaucoma...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2019.056

    authors: Zhou RR,Li HB,You QS,Rong R,You ML,Xiong K,Huang JF,Xia XB,Ji D

    更新日期:2019-12-01 00:00:00

  • Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.

    abstract::Newcastle disease virus (NDV) is a naturally oncolytic virus that has been shown to be safe and effective for cancer therapy. Tumor virotherapy using NDV emerged in the 1950s and has advanced more recently by the increased availability of reverse genetics technology. In this study, we constructed a reverse genetics sy...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.207

    authors: Wei D,Sun N,Nan G,Wang Y,Liu HQ,Peeters B,Chen ZN,Bian H

    更新日期:2012-07-01 00:00:00

  • Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapy.

    abstract::Human papillomavirus type 16 (HPV16) is associated with the development of anogenital cancers and their precursor lesions, intraepithelial neoplasia. Treatment strategies against HPV-induced intraepithelial neoplasia are not HPV specific and mostly consist of physical removal or ablation of lesions. We had previously ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.115

    authors: Sharma R,Palefsky JM

    更新日期:2010-07-01 00:00:00

  • Ultrasound enhances gene delivery of human factor IX plasmid.

    abstract::Delivery of plasmid DNA can be enhanced by treatment with ultrasound (US); acoustic cavitation appears to play an important role in the process. Ultrasound contrast agents (UCAs; stabilized microbubbles) nucleate acoustic cavitation, and lower the acoustic pressure threshold for inertial cavitation occurrence. Fifty m...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.893

    authors: Miao CH,Brayman AA,Loeb KR,Ye P,Zhou L,Mourad P,Crum LA

    更新日期:2005-07-01 00:00:00

  • Regulatory and ethical issues for phase I in utero gene transfer studies.

    abstract::Clinical gene transfer research has involved adult and child subjects, and it is expected that gene transfer in fetal subjects will occur in the future. Some genetic diseases have serious adverse effects on the fetus before birth, and there is hope that prenatal gene therapy could prevent such disease progression. Res...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.062

    authors: Strong C

    更新日期:2011-11-01 00:00:00

  • PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.

    abstract::Systemic administration of adenoviral vectors leads to activation of innate and antigen-specific immunity. In an attempt to diminish T and B cell-specific immune responses to E1-deleted adenoviral vectors, capsid proteins were modified with various activated monomethoxypolyethylene glycols (MPEGs). The impact of this ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402760372972

    authors: Croyle MA,Chirmule N,Zhang Y,Wilson JM

    更新日期:2002-10-10 00:00:00

  • Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors.

    abstract::Targeted vectors provide a number of advantages for systemic and local gene delivery strategies. Several groups have investigated the utility of using various ligands to alter the tropism of adenovirus (Ad) vectors. We have previously demonstrated that fibroblast growth factor (FGF) ligands can specifically target DNA...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050016265

    authors: Printz MA,Gonzalez AM,Cunningham M,Gu DL,Ong M,Pierce GF,Aukerman SL

    更新日期:2000-01-01 00:00:00

  • Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.

    abstract::The purpose of this study was to determine the safety and antitumor activity of IFN-gamma retroviral vector in patients with advanced melanoma. Seventeen patients (9 single courses, 8 multiple courses) received a total of 363 intratumor injections of IFN-gamma retroviral vector (1 x 10(7) PFU/ml administered at 0.3, 0...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/10430349950017978

    authors: Nemunaitis J,Fong T,Burrows F,Bruce J,Peters G,Ognoskie N,Meyer W,Wynne D,Kerr R,Pippen J,Oldham F,Ando D

    更新日期:1999-05-20 00:00:00

  • Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo.

    abstract::Replication-deficient adenoviruses are known to induce acute injury and inflammation of infected tissues, thus limiting their use for human gene therapy. However, molecular mechanisms triggering this response have not been fully defined. To characterize this response, chemokine expression was evaluated in DBA/2 mice f...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018364

    authors: Muruve DA,Barnes MJ,Stillman IE,Libermann TA

    更新日期:1999-04-10 00:00:00

  • Transient transfection methods for clinical adeno-associated viral vector production.

    abstract::Recombinant adeno-associated virus (AAV)-based vectors expressing therapeutic gene products have shown great potential for human gene therapy. One major challenge for translation of promising research to clinical development is the manufacture of sufficient quantities of AAV vectors that meet stringent standards for p...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2009.064

    authors: Wright JF

    更新日期:2009-07-01 00:00:00

  • CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.

    abstract::Recent advances in genome sequencing have greatly improved our ability to understand and identify the causes of genetic diseases. However, there remains an urgent need for innovative, safe, and effective treatments for these diseases. CRISPR-based genome editing systems have become important and powerful tools in the ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.111

    authors: Carlaw TM,Zhang LH,Ross CJD

    更新日期:2020-08-01 00:00:00

  • Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells.

    abstract::Cell encapsulation offers a safe and manufacturable method for the systemic delivery of therapeutic proteins from genetically engineered cells. However, control of dose delivery remains a major issue with regard to clinical application. We generated populations of immortalized murine NIH 3T3 fibroblasts that secrete m...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018823

    authors: Serguera C,Bohl D,Rolland E,Prevost P,Heard JM

    更新日期:1999-02-10 00:00:00

  • Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.

    abstract::As an alternative to virus-mediated gene transfer, we previously demonstrated a simple, safe, and efficient transfer of foreign gene into the central nervous system using continuous injection of a plasmid DNA-cationic liposome complex. To explore whether this approach can be applied to the treatment of certain neurolo...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.7-1093

    authors: Imaoka T,Date I,Ohmoto T,Nagatsu T

    更新日期:1998-05-01 00:00:00

  • ssDNA and the Argonautes: The Quest for the Next Golden Editor.

    abstract::Genome engineering has gone mainstream because of breakthroughs in defining and harnessing naturally occurring, customizable DNA recognition cursors (protein or RNA-guided). At present, most gene editing relies on these cursors to direct custom DNA endonucleases to a specific genomic sequence to induce a double-strand...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.071

    authors: Martínez-Gálvez G,Ata H,Campbell JM,Ekker SC

    更新日期:2016-06-01 00:00:00

  • Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

    abstract::MDA-MB-231, an HLA-A2(+), HER2/neu(+) allogeneic breast cancer cell line genetically modified to express the costimulatory molecule CD80 (B7-1), was used to vaccinate 30 women with previously treated stage IV breast cancer. Expression of CD80 conferred the ability to deliver a costimulatory signal and thereby improved...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/104303403322124828

    authors: Dols A,Smith JW 2nd,Meijer SL,Fox BA,Hu HM,Walker E,Rosenheim S,Moudgil T,Doran T,Wood W,Seligman M,Alvord WG,Schoof D,Urba WJ

    更新日期:2003-07-20 00:00:00

  • Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo.

    abstract::The addition of replication-defective recombinant adenovirus to plasmid transfection (termed here "adenofection") has been shown to increase plasmid transgene expression in limited studies. Similarly, the addition of cationic liposomes to adenovirus increases adenovirus-mediated gene transduction (termed here "lipoduc...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017059

    authors: Dunphy EJ,Redman RA,Herweijer H,Cripe TP

    更新日期:1999-09-20 00:00:00

  • Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.

    abstract::Twenty-eight patients with advanced neovascular age-related macular degeneration (AMD) were given a single intravitreous injection of an E1-, partial E3-, E4-deleted adenoviral vector expressing human pigment epithelium- derived factor (AdPEDF.11). Doses ranging from 10(6) to 10(9.5) particle units (PU) were investiga...

    journal_title:Human gene therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1089/hum.2006.17.167

    authors: Campochiaro PA,Nguyen QD,Shah SM,Klein ML,Holz E,Frank RN,Saperstein DA,Gupta A,Stout JT,Macko J,DiBartolomeo R,Wei LL

    更新日期:2006-02-01 00:00:00

  • Insulin Therapy Improves Adeno-Associated Virus Transduction of Liver and Skeletal Muscle in Mice and Cultured Cells.

    abstract::Adeno-associated virus (AAV) gene transfer is a promising treatment for genetic abnormalities. Optimal AAV vectors are showing success in clinical trials. Gene transfer to skeletal muscle and liver is being explored as a potential therapy for some conditions, that is, α1-antitrypsin (AAT) disorder and hemophilia B. Ex...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2016.073

    authors: Carrig S,Bijjiga E,Wopat MJ,Martino AT

    更新日期:2016-11-01 00:00:00

  • Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates.

    abstract::An E1-, E2a-, E3-deleted adenoviral vector (Av3H82) encoding an epitope-tagged B domain-deleted human factor VIII cDNA (flagged FVIII) was evaluated in nonhuman primates. Twelve cynomolgus monkeys received intravenous administration of Av3H82; 6 monkeys received 6 x 10(11) particles/kg and another 6 received 3 x 10(12...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016401

    authors: Brann T,Kayda D,Lyons RM,Shirley P,Roy S,Kaleko M,Smith T

    更新日期:1999-12-10 00:00:00

  • Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.

    abstract::Approaches to alter the native tropism of adenoviruses (Ads) are beneficial to increase their efficacy and safety profile. Liver tropism is important with regard to potential clinical toxicity in humans. Ad5/3 chimeras in which the Ad5 knob is substituted by the Ad3 knob, such as Ad5/3luc1, have been recently shown to...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340460745829

    authors: Breidenbach M,Rein DT,Wang M,Nettelbeck DM,Hemminki A,Ulasov I,Rivera AR,Everts M,Alvarez RD,Douglas JT,Curiel DT

    更新日期:2004-05-01 00:00:00

  • A novel imaging approach for single-cell, real-time analysis of oncolytic virus replication and efficacy in cancer cells.

    abstract::Oncolytic viruses (OV) are novel cancer gene therapies that are moving toward the forefront of modern medicines. However, their full therapeutic potential is hindered by the lack of convenient and reliable strategies to visualize and quantify OV growth kinetics and therapeutic efficacy in live cells. Here, we present ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.294

    authors: Quillien L,Top S,Kappler S,Redouté A,Dusetti N,Quentin-Froignant C,Lulka H,Camus C,Buscail L,Gallardo F,Bertagnoli S,Cordelier P

    更新日期:2021-01-27 00:00:00

  • Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter.

    abstract::The hepatocarcinoma-intestine-pancreas (HIP) gene, also called pancreatitis-associated protein-1 (PAP1) or Reg IIIalpha, is activated in most human hepatocellular carcinomas (HCCs) but not in normal liver, which suggests that HIP regulatory sequence could be used as efficient liver tumor-specific promoters to express ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.153

    authors: Hervé J,Cunha AS,Liu B,Valogne Y,Longuet M,Boisgard R,Brégerie O,Roux J,Guettier C,Calès P,Tavitian B,Samuel D,Clerc J,Bréchot C,Faivre J

    更新日期:2008-09-01 00:00:00

  • Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation.

    abstract::Adenovirus type 5 (Ad5) is a commonly used vector for gene therapy, but its efficacy is limited by high seroprevalence and off-target hepatic and splenic sequestration. In order to circumvent these limitations, the use of vectors derived from rare species adenoviruses is appealing. The opportunity to retarget rare spe...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2014.016

    authors: Coughlan L,Uusi-Kerttula H,Ma J,Degg BP,Parker AL,Baker AH

    更新日期:2014-04-01 00:00:00

  • Virotherapy Research in Germany: From Engineering to Translation.

    abstract::Virotherapy is a unique modality for the treatment of cancer with oncolytic viruses (OVs) that selectively infect and lyse tumor cells, spread within tumors, and activate anti-tumor immunity. Various viruses are being developed as OVs preclinically and clinically, several of them engineered to encode therapeutic prote...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2017.138

    authors: Ungerechts G,Engeland CE,Buchholz CJ,Eberle J,Fechner H,Geletneky K,Holm PS,Kreppel F,Kühnel F,Lang KS,Leber MF,Marchini A,Moehler M,Mühlebach MD,Rommelaere J,Springfeld C,Lauer UM,Nettelbeck DM

    更新日期:2017-10-01 00:00:00

  • Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.

    abstract::Aberrant JAK/STAT3 pathway has been reported to be related to hepatocellular carcinoma (HCC) in many cell lines. In this study, a double-regulated oncolytic adenovirus vector that can replicate and induce a cytopathic effect in alpha-fetoprotein (AFP)-positive HCC cell lines with p53 dysfunction was successfully const...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.219

    authors: Wei RC,Cao X,Gui JH,Zhou XM,Zhong D,Yan QL,Huang WD,Qian QJ,Zhao FL,Liu XY

    更新日期:2011-09-01 00:00:00

  • Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficien

    abstract::Despite efforts toward improvements in retrovirus-mediated gene transfer, stable high-level expression of a therapeutic gene in human hematopoietic stem cells remains a great challenge. We have evaluated the efficiency of different viral long terminal repeats (LTRs) in long-term expression of a transgene in vivo, usin...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401450942

    authors: Kaneko S,Onodera M,Fujiki Y,Nagasawa T,Nakauchi H

    更新日期:2001-01-01 00:00:00

  • Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy.

    abstract::Murine skeletal muscle cells transduced with foreign genes and tissue engineered in vitro into bioartificial muscles (BAMs) are capable of long-term delivery of soluble growth factors when implanted into syngeneic mice (Vandenburgh et al., 1996b). With the goal of developing a therapeutic cell-based protein delivery s...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018643

    authors: Powell C,Shansky J,Del Tatto M,Forman DE,Hennessey J,Sullivan K,Zielinski BA,Vandenburgh HH

    更新日期:1999-03-01 00:00:00